(Q44733700)

5 December 2017

title

Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera (English)

1 reference

5 December 2017

0 references

0 references

1 reference

Tania Borda

1

1 reference

5 December 2017

Ricardo Gomez

series ordinal

2

1 reference

5 December 2017

Maria I Berría

series ordinal

3

1 reference

5 December 2017

Leonor Sterin-Borda

series ordinal

4

1 reference

5 December 2017

language of work or name

1 reference

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

45

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

144-154

1 reference

Involvement of endogenous nitric oxide signalling system in brain muscarinic acetylcholine receptor activation

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Potential role of muscarinic receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Circulating antibodies to guanosine in systemic lupus erythematosus: correlation with nephritis and polyserositis by acute and longitudinal analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Memory functions and temporal-limbic morphology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Glial cell abnormalities in major psychiatric disorders: the evidence and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Increased prevalence of antibrain antibodies in the sera from schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Astrocytes have both M1 and M2 muscarinic receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Astroglial function of schizophrenic brain: a study using lobotomized brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Immunoglobulin binding to brain in autoimmune mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

In vivo immunomodulatory effects of clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Exposure to Prenatal and Childhood Infections and the Risk of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Decreased interleukin-2 production in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Immunological influences in attention-deficit disorder and schizophrenia; is there a link between these two conditions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Colocalization of neurotransmitter receptors on astrocytes in explant cultures of rat CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Serum interleukin-6 in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Astrocyte differentiation induced by Junín virus in rat brain cell cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Antibodies against cerebral M1 cholinergic muscarinic receptor from schizophrenic patients: molecular interaction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Serum immunoglobulin concentrations in patients admitted to an acute psychiatric in-patient service

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

The "antibrain" factors in psychiatric patients' sera. I. Further studies with a hemagglutination technique.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Natural autoantibodies in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Autoimmunity in schizophrenia: a review of recent findings

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

https://api.crossref.org/works/10.1002%2FGLIA.10312

1 reference

7 January 2021

Stimulated lymphocytes in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Autoradiographic localization of binding sites for muscarinic and nicotinic agonists and antagonists on cultured astrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Schizophrenia and autoimmunity--a possible etiological mechanism?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10312

7 January 2021

Identifiers

DOI

10.1002/GLIA.10312

1 reference

5 December 2017

1 reference